Cannabis use is associated with double the risk of diabetic ketoacidosis among patients with type 1 diabetes, according to a research letter published Nov. 5 in JAMA Internal Medicine.

A 13-year study of type 2 diabetes patients has found metformin, one of the world’s highest-grossing anti-diabetic medications, could be protective against age-related macular degeneration, a leading cause of blindness in Americans older than 50.

Antibiotic prescriptions to prevent infective endocarditis (IE) decreased following a 2007 guideline update from the American Heart Association—even among high-risk patients for whom antibiotics were still recommended. Those patients showed an estimated 177 percent increase in IE incidence over the next several years, according to a new study.

Low-risk patients with mild hypertension derived no protective benefit from blood pressure drugs over 5.8 years of follow-up but had an increased risk of adverse effects potentially related to the medication, researchers reported in a new study.

The FDA has announced a Class I recall for 1.1 million packages of CoaguChek XS PT test strips used with point-of-care or in-home devices to adjust warfarin dosing.

Ischemic stroke patients—regardless of their individual characteristics or the severity of their stroke—are 20 percent more likely to be readmitted to the hospital within 30 days of discharge if they acquire any kind of infection during their initial stay, researchers reported Nov. 1 in Stroke.

Eight European scientific societies joined forces to produce what they say is the first interdisciplinary position paper to help clinicians manage patients with patent foramen ovales (PFOs).

Physicians successfully reversed the bleeding risk-treatment paradox in percutaneous coronary intervention (PCI) by prioritizing risk-concordant use of bleeding avoidance strategies like bivalirudin, radial access and vascular closure devices, according to a report published Oct. 31 in the Journal of the American Heart Association.